|
|
|
Corporate Profile: Circadian Technologies
| Summary: |
Circadian Technologies is focused on the research, development, and commercialization of therapeutics and diagnostics related to VEGF for treatment and diagnosis of patients with cancer.
|
| Address (HQ): |
Suite 0403
Level 4
650 Chapel Street
South Yarra, VIC 3141
Australia |
| Phone
#'s (HQ): |
| Main |
+61 3 9826 0399 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
+61 3 9824 0083 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
